← Leaderboards
Janet Anne Houghton
St. Jude Children'S Research Hospital
$8,199,871
Attributed
$8,552,896
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $862.5K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$8,552,896 · 7
By mechanism
R01$6,545,875 · 4
P01$1,477,484 · 2
P50$529,537 · 1
Top collaborators
- Nathan A. Berger4 shared
- Neal J Meropol4 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Jun Yang$3,072,061
- Xiang Chen$2,994,809
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineRhabdomyosarcomaApoptosisHuman TissueNeoplasm /Cancer ChemotherapyXenotransplantationCytotoxicityBasePhosphorylationInterferon GammaTransfectionDna DamageProgramsLaboratory MouseScienceInhibitor/AntagonistProteinsScid MouseCellsSignal PathwayCell DeathMolecularBiological Signal TransductionSignal Transduction
Grant awards (33)
Targeting GLI-dependent Transcription by GANT61 in Colon Cancer$548,628
R01 · FY2016 · CA · contact PI
Targeting GLI-dependent Transcription by GANT61 in Colon Cancer$362,569
R01 · FY2015 · CA · contact PI
Career Development Program$133,737
P50 · FY2015 · CA
Career Development Program$131,599
P50 · FY2014 · CA
Career Development Program$126,111
P50 · FY2013 · CA
Career Development Program$138,090
P50 · FY2012 · CA
TRAIL Therapy for Rhabdomyosacrcoma$227,795
R01 · FY2011 · CA · contact PI
TRAIL Therapy for Rhabdomyosacrcoma$234,840
R01 · FY2010 · CA · contact PI
TRAIL Therapy for Rhabdomyosacrcoma$234,840
R01 · FY2009 · CA · contact PI
TRAIL Therapy for Rhabdomyosacrcoma$234,840
R01 · FY2008 · CA · contact PI
SELECTIVE THERAPY FOR COLON CARCINOMA$309,836
R01 · FY2007 · CA · contact PI
Development Therapy for Metastatic Colorectal Cancer$253,422
R01 · FY2007 · CA · contact PI
TRAIL Therapy for Rhabdomyosacrcoma$234,840
R01 · FY2007 · CA · contact PI
SELECTIVE THERAPY FOR COLON CARCINOMA$309,795
R01 · FY2006 · CA · contact PI
Development Therapy for Metastatic Colorectal Cancer$282,595
R01 · FY2006 · CA · contact PI
SELECTIVE THERAPY FOR COLON CARCINOMA$317,250
R01 · FY2005 · CA
Development Therapy for Metastatic Colorectal Cancer$296,250
R01 · FY2005 · CA
TRAIL Therapy for Rhabdomyosarcoma$249,000
R01 · FY2005 · CA
SELECTIVE THERAPY FOR COLON CARCINOMA$317,250
R01 · FY2004 · CA
TRAIL Therapy for Rhabdomyosarcoma$249,000
R01 · FY2004 · CA
SELECTIVE THERAPY FOR COLON CARCINOMA$317,250
R01 · FY2003 · CA
TRAIL Therapy for Rhabdomyosarcoma$249,000
R01 · FY2003 · CA
SELECTIVE THERAPY FOR COLON CARCINOMA$281,825
R01 · FY2002 · CA
TRAIL Therapy for Rhabdomyosarcoma$248,447
R01 · FY2002 · CA
RHABDOSARCOMA--DIFFERENTIATION AND THERAPY$285,821
P01 · FY2001 · CA
P53 GENE AND CHEMOSENSITIVITY$285,821
P01 · FY2001 · CA
P53 GENE AND CHEMOSENSITIVITY$285,821
P01 · FY2001 · CA
RHABDOSARCOMA--DIFFERENTIATION AND THERAPY$285,821
P01 · FY2001 · CA
SELECTIVE THERAPY FOR COLON CARCINOMA$273,616
R01 · FY2001 · CA
TRAIL Therapy for Rhabdomyosarcoma$247,340
R01 · FY2001 · CA
SELECTIVE THERAPY FOR COLON CARCINOMA$265,647
R01 · FY2000 · CA
P53 GENE AND CHEMOSENSITIVITY$167,100
P01 · FY2000 · CA
RHABDOSARCOMA--DIFFERENTIATION AND THERAPY$167,100
P01 · FY2000 · CA